BSX : Summary for Boston Scientific Corporation C - Yahoo Finance

U.S. Markets closed

Boston Scientific Corporation (BSX)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
20.35+0.26 (+1.29%)
At close: 4:01 PM EST
People also watch:
STJMDTBAXBCRBDX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close20.09
Open20.13
Bid19.59 x 300
Ask21.39 x 300
Day's Range20.03 - 20.55
52 Week Range15.67 - 24.79
Volume10,982,710
Avg. Volume9,123,247
Market Cap27.71B
Beta0.63
PE Ratio (TTM)383.96
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barclays PLC (ADR) (BCS): Are Hedge Funds Right About This Stock?
    Insider Monkey8 hours ago

    Barclays PLC (ADR) (BCS): Are Hedge Funds Right About This Stock?

    Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us with significant returns as well. Many hedge funds, like Paul Singer’s Elliott Management, are pretty secretive, but we can still get some insights by analyzing […]

  • Boston Scientific Acquisition Eyes Rivals Edwards, Medtronic
    Investor's Business Daily2 days ago

    Boston Scientific Acquisition Eyes Rivals Edwards, Medtronic

    Boston Scientific is prepping to take on Edward Lifesciences and Medtronic with its acquisition of Neovasc's advanced tissue business.

  • Market Realist3 days ago

    Boston Scientific Completes Its Acquisition of EndoChoice

    On November 22, 2016, Boston Scientific (BSX) announced the completion of its acquisition of EndoChoice Holdings. The deal was valued at $210 million in cash at a price of $8.00 per share.